General Introduction and Thesis Outline | 21 18. Towbin JA, McKenna WJ, Abrams DJ, et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm. 2019;16(11):e301– 72. 19. Haugaa KH, Basso C, Badano LP, et al. Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy - an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2017;18(3):237–53. 20. Teske AJ, Cox MGPJ, Te Riele ASJM, et al. Early detection of regional functional abnormalities in asymptomatic ARVD/C gene carriers. J American Soc Echocardiogr. 2012;25(9):997–1006. 21. Réant P, Hauer AD, Castelletti S, et al. Epicardial myocardial strain abnormalities may identify the earliest stages of arrhythmogenic cardiomyopathy. Int J Cardiovasc Imaging. 2016;32(4):593–601. 22. Taha K, Mast TP, Cramer MJ, et al. Evaluation of Disease Progression in Arrhythmogenic Cardiomyopathy: The Change of Echocardiographic Deformation Characteristics Over Time. JACC Cardiovasc Imaging. 2019;13(2):631–4. 23. Mast TP, Taha K, Cramer MJ, et al. The Prognostic Value of Right Ventricular Deformation Imaging in Early Arrhythmogenic Right Ventricular Cardiomyopathy. JACC Cardiovasc Imaging. 2019;12(3):446–55. 24. Sarvari SI, Haugaa KH, Anfinsen OG, et al. Right ventricular mechanical dispersion is related to malignant arrhythmias: A study of patients with arrhythmogenic right ventricular cardiomyopathy and subclinical right ventricular dysfunction. Eur Heart J. 2011;32(9):1089–96. 25. Leren IS, Saberniak J, Haland TF, Edvardsen T, Haugaa KH. Combination of ECG and Echocardiography for Identification of Arrhythmic Events in Early ARVC. JACC Cardiovasc Imaging. 2017;10(5):503–13. 26. Bosman LP, Cadrin-Tourigny J, Bourfiss M, et al. Diagnosing arrhythmogenic right ventricular cardiomyopathy by 2010 task force criteria: Clinical performance and simplified practical implementation. Europace. 2020;22(5):787–96. 27. van der Pols MJ, Mast TP, Loh P, et al. Clinical characterisation and risk stratification of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy ≥50 years of age. Netherlands Heart Journal. 2016;24(12):740–7. 28. Charron P, Arad M, Arbustini E, et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2010;31(22):2715–26. 29. Dejgaard LA, Skjølsvik ET, Lie ØH, et al. The Mitral Annulus Disjunction Arrhythmic Syndrome. J Am Coll Cardiol. 2018;72(14):1600–9. 30. Essayagh B, Sabbag A, El-Am E, Cavalcante JL, Michelena HI, Enriquez-Sarano M. Arrhythmic mitral valve prolapse and mitral annular disjunction: pathophysiology, risk stratification, and management. Eur Heart J. 2023;44(33):3121–35. 1
RkJQdWJsaXNoZXIy MTk4NDMw